Oral interferon-alpha lozenges: Phase III start

This month, Intas will begin a double-blind, placebo-controlled, Indian Phase III trial to evaluate oral interferon-alpha lozenges in up to 520 patients with influenza-like symptoms. Intas has Indian ...